Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-26

FDA Approved: XTAMPZA ER — Original Application (Collegium Pharmaceutical, Inc.)

View source ↗

Summary

The FDA approved XTAMPZA ER, an extended-release oxycodone product from Collegium Pharmaceutical, for the management of chronic pain in adults requiring around-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XTAMPZA ER (Oxycodone)

Snippet

ORIG AP for XTAMPZA ER (OXYCODONE)